Abstract：Objective: To observe the efficacy of interferon combined with montelukast and vitamin D in the treatment of asthmatic bronchitis. Methods: A total of 96 children patients with asthmatic bronchitis admitted to pediatric department of our hospital from March 2016 to September 2018 were selected and divided into observation group and control group according to the random number table method, with 48 cases in each group. Control group was given montelukast combined with vitamin D, and observation group was given interferon on this basis, and 7d was taken as one course of treatment. The efficacy and immune function were analyzed in the two groups after the end of one course of treatment, and the adverse drug reactions and recurrence rate within 6 months were observed. Results: The remission times of symptoms of wheezing, cough and lung wheezing rale and hospital stay in observation group were significantly lower than those in control group (P<0.05). There was a statistically significant difference in the clinical efficacy between the two groups (P<0.05), and the total effective rate in observation group was significantly higher than that in control group (92.00% & 76.00%) (P<0.05). After treatment, the levels of IgA, CD4+ and CD4+/CD8+ in the two groups were significantly higher than those before treatment (P<0.05) while the levels of IgE and CD8+ were significantly lower than those before treatment (P<0.05), and the increases of IgA, CD4+ and CD4+/CD8+ and decreases of IgE and CD8+ in observation group were greater than those in control group (P<0.05). There was no significant difference in the incidence rate of adverse reactions between the two groups (8.33% & 6.25%) (P>0.05). Within 6 months, the recurrence rate in observation group was significantly lower than that in control group (4.17% & 18.72%) (P<0.05). Conclusion: Interferon combined with montelukast and vitamin D in the treatment of asthmatic bronchitis can effectively alleviate symptoms, improve clinical efficacy, improve immune function and reduce the recurrence rate of children with asthmatic bronchitis. It is safe and has clinical application value.
孙萌, 谷名晓. 干扰素联合孟鲁司特维生素D治疗喘息性支气管炎的疗效分析[J]. 河北医学, 2019, 25(11): 1805-1809.
SUN Meng, GU Mingxiao. Therapeutic Effect of Interferon combined with Montelukast and Vitamin D on Asthmatic Bronchitis. HeBei Med, 2019, 25(11): 1805-1809.
2019, Vol. 25 
冀公网安备13080202000677号